| Name | Title | Contact Details |
|---|
Ovid Therapeutics is a biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders. Ovid`s drug candidate, OV101, is currently in development for the treatment of symptoms of Angelman syndrome and Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies. Ovid has initiated the Phase 2 STARS trial of OV101 in adults with Angelman syndrome and a Phase 1 trial in adolescents with Angelman and Fragile X syndrome to identify doses suitable for younger patients.
BVI has been providing affordable alcohol/substance abuse treatment to patients in need for more than twenty-three years now. Of those 23 years, I have had the privilege of directing that treatment for over 14 years. In the early days we treated about
True North Consulting is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CHS Therapy and Rehab helps post-acute rehab centers create impactful care programs that lead to exceptional patient outcomes.